- Home
- ASST vs ATRC Comparison
ASST vs ATRC Comparison
Compare ASST & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASST
- ATRC
- Stock Information
- Founded
- ASST 2020
- ATRC 2000
- Country
- ASST United States
- ATRC United States
- Employees
- ASST N/A
- ATRC N/A
- Industry
- ASST Computer Software: Prepackaged Software
- ATRC Medical/Dental Instruments
- Sector
- ASST Technology
- ATRC Health Care
- Exchange
- ASST Nasdaq
- ATRC Nasdaq
- Market Cap
- ASST 1.7B
- ATRC 1.7B
- IPO Year
- ASST 2023
- ATRC 2005
- Fundamental
- Price
- ASST $1.25
- ATRC $35.44
- Analyst Decision
- ASST
- ATRC Strong Buy
- Analyst Count
- ASST 0
- ATRC 10
- Target Price
- ASST N/A
- ATRC $49.60
- AVG Volume (30 Days)
- ASST 110.7M
- ATRC 358.5K
- Earning Date
- ASST 11-13-2025
- ATRC 10-29-2025
- Dividend Yield
- ASST N/A
- ATRC N/A
- EPS Growth
- ASST N/A
- ATRC N/A
- EPS
- ASST N/A
- ATRC N/A
- Revenue
- ASST $4,953,567.00
- ATRC $499,946,000.00
- Revenue This Year
- ASST N/A
- ATRC $16.32
- Revenue Next Year
- ASST N/A
- ATRC $12.37
- P/E Ratio
- ASST N/A
- ATRC N/A
- Revenue Growth
- ASST 49.00
- ATRC 16.28
- 52 Week Low
- ASST $0.34
- ATRC $27.71
- 52 Week High
- ASST $13.42
- ATRC $43.11
- Technical
- Relative Strength Index (RSI)
- ASST 39.17
- ATRC 44.80
- Support Level
- ASST $0.78
- ATRC $35.93
- Resistance Level
- ASST $1.81
- ATRC $38.42
- Average True Range (ATR)
- ASST 0.19
- ATRC 1.37
- MACD
- ASST 0.16
- ATRC -0.07
- Stochastic Oscillator
- ASST 44.34
- ATRC 21.06
About ASST Asset Entities Inc. Class B
Strive Inc is engaged in providing investment advisory, wealth management, and consulting services through its subsidiary. Its objectives is to (i) accumulate Bitcoin; (ii) increase Bitcoin-per-share; and (iii) outperform Bitcoin over the long run by deploying both beta Bitcoin treasury accumulation strategies and alpha investment strategies with the goal of beating Bitcoin's investment performance as the hurdle rate.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.